According to Codexis 's latest financial reports the company's total liabilities are $49.94 M. A companyโs total liabilities is the sum of all current and non-current debts and obligations.
Year | Total liabilities | Change |
---|---|---|
2023-12-31 | $49.94 M | -52.7% |
2022-12-31 | $0.10 B | 28.79% |
2021-12-31 | $81.99 M | 59.07% |
2020-12-31 | $51.54 M | 18.34% |
2019-12-31 | $43.55 M | 89.56% |
2018-12-31 | $22.97 M | -20.98% |
2017-12-31 | $29.07 M | 75.71% |
2016-12-31 | $16.54 M | -23.98% |
2015-12-31 | $21.76 M | -0.2% |
2014-12-31 | $21.81 M | 25.66% |
2013-12-31 | $17.35 M | -19.36% |
2012-12-31 | $21.52 M | -35.23% |
2011-12-31 | $33.23 M | -2.08% |
2010-12-31 | $33.93 M | -86.08% |
2009-12-31 | $0.24 B | 21.94% |
2008-12-31 | $0.20 B | -0.5% |
2007-12-31 | $0.20 B | 102.17% |
2006-12-31 | $99.42 M |
Company | Total liabilities | differencediff. | Country |
---|---|---|---|
Pfizer PFE | $137.21 B | 274,622.70% | ๐บ๐ธ USA |
Merck MRK | $69.04 B | 138,129.29% | ๐บ๐ธ USA |
Dupont De Nemours DD | $13.82 B | 27,583.90% | ๐บ๐ธ USA |
Balchem BCPC | $0.54 B | 987.63% | ๐บ๐ธ USA |